galactose has been researched along with coenzyme q10 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvares, E; Cardile, V; Costantino-Ceccarini, E; Mazzone, D; Pannuzzo, G; Perciavalle, V | 1 |
| Pan, J; Wang, B; Wang, J; Wang, Y; Yan, B; Yu, S; Yuan, Z; Zhang, C; Zhang, D; Zhang, L | 1 |
| Lucangioli, S; Martinefski, MR; Masotta, NE; Rojas, AM; Tripodi, VP | 1 |
3 other study(ies) available for galactose and coenzyme q10
| Article | Year |
|---|---|
A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice.
Topics: Animals; Antioxidants; Apoptosis; Cell Survival; Cells, Cultured; Disease Models, Animal; Female; Galactose; Glutathione; Humans; Isoflavones; Leukodystrophy, Globoid Cell; Male; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Oligodendroglia; Psychosine; Ubiquinone; Xanthophylls | 2010 |
Coenzyme Q10 inhibits the aging of mesenchymal stem cells induced by D-galactose through Akt/mTOR signaling.
Topics: Animals; Bone Marrow Cells; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Galactose; Mesenchymal Stem Cells; Mitochondria; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Ubiquinone | 2015 |
High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation.
Topics: Administration, Oral; Antioxidants; Cellulose; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Stability; Hexoses; Lecithins; Organic Chemicals; Solubility; Surface-Active Agents; Triglycerides; Ubiquinone | 2019 |